- Drug-drug interactions and QT prolongation as a commonly assessed cardiac
- This publication provides an overview of published clinical studies on pharmacokinetic and/or pharmacodynamic drug-drug interactions in humans and their electrophysiological consequences (QT interval modification).
- Opioid Withdrawal: A New Look at Medication Options
- Opioid dose reduction or transition to another opioid therapy often results in uncomfortable signs and symptoms of withdrawal.
- The promise and pitfalls of intranasally administering psychopharmacological
- For instance, Miller et al. compared the pharmacokinetics of intranasal haloperidol with i.v.
- Tranquillisation of patients with aggressive or challenging behaviour
- Diazepam should not be used intramuscularly for rapid tranquillisation, and the response with intravenous use is less predictable, and also increases the patient's risk of respiratory depression.
- Why do we hiccup?
- In severe and persistent cases, physicians may treat hiccups with various drugs — chlorpromazine, haloperidol, baclofen, metoclopramide, gabapentin, proton-pump inhibitors — although there is little reliable evidence for their effectiveness.
Haloperidol Pharmacokinetics is described in multiple online sources, as addition to our editors' articles, see section below for printable documents, Haloperidol Pharmacokinetics books and related discussion.